Bring your own decision: An alternative perspective


Did you know that 74% of enterprise mobility programs use bring your own device (BYOD)? That’s because effectively managed BYOD saves employees 81 minutes per week and their employer $1,300 per year. Do we have your attention?

Traditionally, BYOD implementation is a gamble. Potential productivity and efficiency gains are weighed against an increased likelihood of security threats. In fact, 35% of companies still don’t feel comfortable making a BYOD decision. As you prepare your program for 2017, here are three BYOD alternatives that may better fit your business needs:

Corporate-owned, personally enabled

In a COPE program, devices are company-owned. While this does burden the enterprise with procurement costs, COPE provides employees with multiple devices and Operating Systems (OSs) to choose from while allowing companies to enjoy hefty carrier discounts usually reserved for Corporate Liable (CL) program hardware, plans, and features.

Unlike BYOD, a pre-approved device and OS selection guarantees compliance with an enterprise’s customised Mobile Device Management (MDM)/Enterprise Mobility Management (EMM) software solution. This maintains corporate data ownership, meaning that enterprises can monitor, manage, and wipe sensitive information as they see fit without worrying about violating the legalities of a particular country or industry.

In addition to security and policy compliance, a limited number of devices and OSs reduces the burden and cost of enterprise mobility support. IT teams don’t have to account for every single device and OS type on the market. End users are also able to keep their personal data and applications separate from enterprise device usage, giving them free reign to use their device as they see fit outside of work.

Choose your own device

CYOD is a blend of BYOD and COPE. While CYOD limits employees to a pre-approved selection of devices and OSs, procurement costs are an employee’s responsibility instead. Because devices, plans, and features are procured individually, companies who utilise CYOD aren’t able to experience the carrier hardware, plan, and feature discounts their COPE counterparts enjoy.

Like COPE programs, CYOD ensures compatibility with an enterprise’s chosen MDM/EMM because devices and OSs must be pre-approved, increasing the level of data privacy and security compared to traditional BYOD. However, Individual Liable (IL) devices are regulated differently in each country and/or industry, meaning that problems can arise when attempting to manage or wipe company data from a device enrolled in a global program.

CYOD reduces support struggles for the same reasons COPE does, but personal and enterprise data isn’t segregated because each employee owns his or her device. This puts company data more at-risk when dangerous or negligent end-user behaviours enters the equation.

Direct-to-carrier stipends

Direct-to-carrier stipends are a fresh approach to traditional BYOD. In this program type, employees are not only responsible for procuring devices, but are also responsible for selecting and paying monthly for their carrier service as well.

Based on job role or some other set of pre-determined criteria, a company utilising stipends simply assigns a monthly credit to each employee that pays a portion of his or her monthly carrier bill. This provides companies huge mobility spend savings, as they’re able to separate personal and corporate usage to avoid certain taxes and regulatory fees traditional BYOD programs can’t.

While direct-to-carrier stipend programs can enforce MDM/EMM enrolment and compliance by suspending or eliminating monthly credits altogether, internal IT support and immediate threat management can be almost impossible because any number of devices and OSs are included and accessing your networks.

The post Bring Your Own Decision appeared first on MOBI.

Related Stories

Leave a comment


This will only be used to quickly provide signup information and will not allow us to post to your account or appear on your timeline.